Brain Atrophy in Multiple Sclerosis: Therapeutic, Cognitive and Clinical Impact
Main Article Content
Downloads
Article Details
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med. 2000;343(13):938-52. DOI: https://doi.org/10.1056/NEJM200009283431307
Cristiano E, Patrucco L, Rojas JI. A systematic review of the epidemiology of multiple sclerosis in South America. Eur J Neurol. 2008;15(12):1273-8. DOI: https://doi.org/10.1111/j.1468-1331.2008.02330.x
Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol. 2008;7(3):268-77. DOI: https://doi.org/10.1016/S1474-4422(08)70042-5
Río J, Nos C, Tintoré M, et al. Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients. Ann Neurol. 2006;59(2):344-52. DOI: https://doi.org/10.1002/ana.20740
Filippi M, Valsasina P, Rocca M. Magnetic resonance imaging of grey matter damage in people with MS. Int MS J. 2007;14(1):12-21.
Calabrese M, Agosta F, Rinaldi F, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol. 2009;66(9):1144-50. DOI: https://doi.org/10.1001/archneurol.2009.174
Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;338(5):278-85. DOI: https://doi.org/10.1056/NEJM199801293380502